Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions

NCT02424305 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: LEO 43204 gel 0.018%
DRUG: LEO 43204 gel 0.1%
DRUG: LEO 43204 gel 0.037%

Sponsor

LEO Pharma